What is ebola
Ebola is a really serious disease with a death rate. Ebola may kill up to 90% of humans affected by it.
Until now, the origin of the disease has been unknown. However, we know that fruit eaters bats are hosts of the virus.
A person who has Ebola virus feels fever, headache, malaise and fatigue. The symptoms resemble those of a simple cold or flu.
One week after, other symptoms appear: nausea, cough, sore throat, frequent vomiting, which may contain blood, frequent diarrhea may also come with blood, bleeding in the eyes, nose, gums.
The most severe stage of the disease is perceived by stains and blood blisters in some parts of the body.
Ebola virus outbreak
The International Federation of Red Cross has worked in 13 countries since March: Guinea, Liberia, Sierra Leone, Nigeria, Ivory Coast, Mali, Senegal, Cameroon, Benin, Togo, Chad, Central African Republic and Gambia.
Forms of prevention
According to the Red Cross, the best form of prevention is to enhance the information that is passed on to the population to prevent the spread of Ebola in Africa.
The coordinator of the Health Emergency Red Cross, said:
“It is crucial to make communities understand what is a treatment center Ebola and accept that in order to help the work of professionals.”
The Ebola disease is severe, but many patients who were infected have healed and became immune. So do not get worried.
So far, ebola is in Africa, but it can reach the entire world. If arriving, health officials know what to do. Moreover, we expect the Ebola vaccine.
The United States government has the rank of Ebola since the year 2009 The patent was registered under CA2741523A1 number.
The media have reported about Ebola vaccine will be used in thousands of Africans in the next year (2015). The World Health Organization said Friday.
“If everything goes well, we may be able to begin using some of these vaccines in some of the affected countries at the very beginning of next year,” said WHO assistant director general Marie-Paule Kieny.
Anyway, many experimental vaccines and therapeutic approaches are being tested, especially in the United States and Canada. In Israel, Vecoy Nanomedicines is developing a biomedical technology platform that tricks a virus into “committing suicide,” which could neutralize viral threats like Ebola, hepatitis and HIV.